Beta

Spending
Congress
Stocks
Lobbying

Spending
Congress
Stocks
Lobbying

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Congress
Stocks
Lobbying

LD-2 disclosure · 2nd Quarter - Report

ALS THERAPY DEVELOPMENT FOUNDATION

via CAPITOL PARTNERS, INC.

2nd Quarter (Apr 1 - June 30) · 2013Posted Jul 15, 2013Filing document ↗LDA record ↗

Income$10Kfee reported

Client

Name: ALS THERAPY DEVELOPMENT FOUNDATION
Description: ALS Medical Research
Location: Massachusetts · United States of America

Registrant

Firm: CAPITOL PARTNERS, INC.
Description: Lobbying
Location: Washington DC, District of Columbia, United States of America

Lobbying activities

1 issue

Budget/Appropriations
Monitor Appropriations for ALS
Lobbyistsmr JONATHAN MICHAEL ORLOFF
TargetedSENATE · HOUSE OF REPRESENTATIVES

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.

ALS THERAPY DEVELOPMENT FOUNDATION — Receipts Report